What is the primary difference between Typical and Atypical antipsychotics regarding receptor binding?

Typical antipsychotics primarily bind to and block Dopamine $D_2$ receptors. Atypical antipsychotics target both Dopamine and Serotonin receptors, which helps treat a broader range of symptoms with fewer motor side effects.

How does the mechanism of SSRIs differ from that of MAOIs?

SSRIs prevent the reabsorption of serotonin into the pre-synaptic neuron by blocking reuptake transporters. MAOIs prevent the breakdown of serotonin and other monoamines by inhibiting the enzyme (Monoamine Oxidase) responsible for their degradation.

When is Electroconvulsive Therapy (ECT) preferred over pharmacological treatment for depression?

ECT is preferred when depression is severe, life-threatening (e.g., high suicide risk), or 'treatment-resistant,' meaning the patient has not responded to multiple trials of different antidepressant medications.

What is a common error in assuming how quickly antidepressants work for a patient?

A common error is expecting immediate mood improvement. While neurochemical changes happen quickly, the 'therapeutic lag' means it usually takes 2 to 6 weeks for the patient to experience a noticeable reduction in depressive symptoms.

Why is it a mistake to prescribe MAOIs without dietary counseling?

MAOIs prevent the breakdown of tyramine, an amino acid found in aged cheeses and cured meats. If a patient consumes these while on MAOIs, it can lead to a hypertensive crisis, which is a dangerous and sudden rise in blood pressure.

What is the danger of confusing Extrapyramidal Symptoms (EPS) with the underlying disorder?

If tremors or muscle rigidity caused by antipsychotics are mistaken for symptoms of schizophrenia, a clinician might incorrectly increase the dosage. This would worsen the physical side effects rather than helping the patient.

Define 'Agranulocytosis' in the context of schizophrenia treatment.

Agranulocytosis is a dangerous drop in white blood cell count that can occur as a side effect of the atypical antipsychotic Clozapine. It requires patients to undergo regular blood monitoring to ensure their immune system remains functional.

What is 'Tardive Dyskinesia'?

Tardive Dyskinesia is a potentially irreversible neurological condition characterized by involuntary, repetitive body movements (like grimacing or eye blinking). It is a long-term side effect associated with chronic use of typical antipsychotics.

What does the term 'Reuptake' refer to in neural communication?

Reuptake is the process by which neurotransmitters are pumped back into the pre-synaptic neuron after being released into the synapse. This process terminates the signal and recycles the neurotransmitter for future use.

How does the Dopamine Hypothesis explain the 'Positive Symptoms' of schizophrenia?

The hypothesis suggests that an excess of dopamine activity in the mesolimbic pathway over-stimulates the brain. This over-stimulation results in 'added' behaviors such as hallucinations, delusions, and disorganized thinking.

Biological Treatments for Schizophrenia & Clinical Depression | OCR GCSE Psychology

1. Neurochemical Foundations of Treatment

The Dopamine Hypothesis: This theory suggests that schizophrenia is caused by an overactive dopamine system, particularly in the mesolimbic pathway. Biological treatments aim to reduce this activity by blocking dopamine receptors, specifically the $D_2$ subtype, to alleviate positive symptoms like hallucinations.
The Monoamine Hypothesis: This framework posits that clinical depression results from a deficiency in neurotransmitters such as serotonin, norepinephrine, and dopamine. Antidepressant medications work by increasing the availability of these chemicals in the synaptic cleft to improve mood and emotional regulation.
Synaptic Transmission: Most biological treatments manipulate the process of neurotransmission, either by inhibiting the reuptake of chemicals into the pre-synaptic neuron or by blocking post-synaptic receptors to prevent over-stimulation.

Diagram of a neural synapse showing neurotransmitter release from the pre-synaptic neuron toward receptors on the post-synaptic neuron.

2. Antipsychotic Medications for Schizophrenia

Typical Antipsychotics (First Generation): These drugs, such as Chlorpromazine, act primarily as dopamine antagonists. They are highly effective at reducing positive symptoms but carry a high risk of extrapyramidal side effects (EPS) like tremors and muscle rigidity.
Atypical Antipsychotics (Second Generation): Newer medications like Clozapine target both dopamine and serotonin receptors. They are generally more effective for negative symptoms (e.g., social withdrawal) and have a lower incidence of motor side effects, though they may cause metabolic issues.
Mechanism of Action: By binding to $D_2$ receptors without activating them, these drugs prevent endogenous dopamine from over-stimulating the brain's reward and sensory processing centers.

3. Antidepressant Drug Classes

Selective Serotonin Reuptake Inhibitors (SSRIs): These are the most common first-line treatments for depression. They work by blocking the reabsorption (reuptake) of serotonin into the pre-synaptic neuron, thereby increasing its concentration in the synapse.
Tricyclic Antidepressants (TCAs): TCAs inhibit the reuptake of both serotonin and norepinephrine. While effective, they are often reserved for cases where SSRIs fail because they interact with more receptor types, leading to more severe side effects like blurred vision and heart rhythm issues.
Monoamine Oxidase Inhibitors (MAOIs): These drugs prevent the enzyme monoamine oxidase from breaking down neurotransmitters. They are highly potent but require strict dietary restrictions to avoid dangerous spikes in blood pressure caused by the amino acid tyramine.

4. Somatic and Brain Stimulation Therapies

Electroconvulsive Therapy (ECT): This involves passing a small electric current through the brain to trigger a brief seizure while the patient is under anesthesia. It is primarily used for severe, treatment-resistant depression and can produce rapid improvements in mood.
Transcranial Magnetic Stimulation (TMS): TMS uses magnetic fields to stimulate nerve cells in the brain regions involved in mood control. Unlike ECT, it does not require anesthesia or induce seizures, making it a non-invasive alternative for moderate depression.
Vagus Nerve Stimulation (VNS): This surgical procedure involves implanting a device that sends regular electrical pulses to the brain via the vagus nerve. It is used as a long-term treatment for chronic depression that has not responded to multiple medications.

5. Key Distinctions in Biological Treatment

Feature	Typical Antipsychotics	Atypical Antipsychotics	SSRIs	TCAs
Primary Target	Dopamine ( $D_2$ )	Dopamine & Serotonin	Serotonin	Serotonin & Norepinephrine
Main Use	Positive Schizophrenia	Positive & Negative Schizophrenia	Clinical Depression	Severe/Resistant Depression
Side Effect Risk	High Motor (EPS)	Metabolic/Weight Gain	Low/Sexual Dysfunction	High/Cardiovascular

Symptom Targeting: It is critical to distinguish between positive symptoms (additions to behavior like hallucinations) and negative symptoms (deficits like lack of motivation). Typical antipsychotics struggle with negative symptoms, whereas atypical ones are more versatile.
Onset of Action: Antidepressants typically require 2-6 weeks of consistent use before therapeutic effects are felt, despite neurochemical changes occurring within hours. This 'therapeutic lag' is a vital concept for patient management.

6. Exam Strategy & Tips

Identify the Mechanism: When asked about a specific drug class, always start by identifying which neurotransmitter it affects and whether it inhibits reuptake, blocks receptors, or inhibits enzymes.
Side Effect Recognition: Exams often test the specific side effects associated with drug generations. Remember that 'Extrapyramidal Symptoms' (EPS) are the hallmark of first-generation antipsychotics, while 'Tyramine interaction' is the classic MAOI trap.
Treatment Resistance: If a scenario describes a patient who has failed multiple drug trials, look for 'Clozapine' (for schizophrenia) or 'ECT' (for depression) as the next logical clinical step.
Check for Contraindications: Always verify if a treatment requires specific lifestyle changes, such as the dietary restrictions for MAOIs or the need for blood monitoring with Clozapine due to agranulocytosis risk.

Biological Treatments for Schizophrenia & Clinical Depression

Summary

1. Neurochemical Foundations of Treatment

2. Antipsychotic Medications for Schizophrenia

3. Antidepressant Drug Classes

4. Somatic and Brain Stimulation Therapies

5. Key Distinctions in Biological Treatment

6. Exam Strategy & Tips

Biological Treatments for Schizophrenia & Clinical Depression

Summary

1. Neurochemical Foundations of Treatment

2. Antipsychotic Medications for Schizophrenia

3. Antidepressant Drug Classes

4. Somatic and Brain Stimulation Therapies

5. Key Distinctions in Biological Treatment

6. Exam Strategy & Tips